Pathology lab merger should make ‘no difference’ to patients, say bosses
Ed Sheridan, Local Democracy Reporter
- Credit: Archant
Patients should “not see any difference” in care following the recent and long-debated reorganisation of local pathology services, according to Homerton Hospital bosses.
The hospital recently merged with the Barts and Lewisham and Greenwich trusts to form the NHS East & South East London Pathology Partnership.
This move to regionalise pathology into a so-called "hub-and-spoke" model has long been a source of concern for local activists, with Hackney Labour voicing concerns in recent years over the potential for delays and errors in treatment.
However, Homerton has reassured patients that they “should not see any differences to what they had expected in the past”.
Chief executive Tracey Fletcher said: “Many of our pathology colleagues will continue to work on site at Homerton and, in due course, will be working in a much improved environment as we move forward with the creation of an essential services laboratory at the hospital.”
The partnership formally launched on May 1, with plans for all laboratories across the three hospitals to operate as a single network by December 2023.
This network will operate labs at the Homerton, Newham, Queen Elizabeth, Royal London, St Bartholomew’s, Whipps Cross Hospitals, as well as University Hospital Lewisham.
- 1 Woman 'may face life-changing injuries' after Dalston e-scooter crash
- 2 Man arrested over two separate rape allegations - one previously unknown to police
- 3 De Beauvoir mother and son campaign to keep the 21 bus route
- 4 Girl reported missing from Hackney found
- 5 Gun found in car as Met makes 130 arrests during drugs op
- 6 Drug dealer jailed after being caught with cannabis and cash
- 7 'Deeply shocked and troubled': Reports of rising anti-Semitic crime
- 8 ‘The people of Edmonton will stop this incinerator’ - Protestors promise more action if plan is signed off
- 9 Man's head and hand slashed in Hackney knife attack
- 10 Dumpling Shack announces plans for Hackney restaurant
It is understood that there were no redundancies as a result of the merger.
While warnings over a potential downgrading of the Homerton’s emergency department or even looming privatisation have not come to pass, local watchdog Healthwatch Hackney continues to have concerns.
Executive director Jon Williams said: “We remain concerned, in spite of assurances that patients will see no change, that the risk of moving any matter around more widely has a risk to it and may result in a poorer service."
He pointed to past warnings from the Royal College of Pathologists that such changes could undermine the quality of pathology.
Healthwatch is also concerned with sickle cell anaemia patients, a condition experienced by many in Hackney’s African-heritage and Turkish communities, receiving quick responses to testing.
But Homerton stressed in the planning phase for the partnership that quick turnaround tests were “non-negotiable” with many tests ran in other hospital's already.
Work will begin on the Homerton’s new Essential Services Lab (ESL) later this summer.